Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

A nationwide clinical trial shows positive results for cancer patients with this common wasting syndrome. Researchers discovered a drug that safely and effectively helped cancer patients when they ...

Meaning, whether you lose weight through a change in your diet, a different medication, or bariatric surgery, there is a risk ...

Ryan Fitzgerald remains perfect in field goal attempts, as he went 2 for 2 in Monday's loss. The best play of the night goes to All-American punter Alex Mastromanno. The senior nailed a 65-yard ...

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...